First, there is a lack of systematic evaluation regarding the biosafety of certain nanomaterials, particularly the in vivo metabolism, accumulation, and immunogenicity of inorganic nanoparticles
This effect may be more noticeable during the initial weeks of treatment with GLP-1 receptor agonists
These studies demonstrated beneficial increases in multiple immune functions, such as a significant increase in NK cell activity, cytokine response, and immune modulation.* The latest study is in the process of peer-review prior to publication
Common mild side effects include nausea, appetite loss, and mild gastrointestinal changes, which typically resolve within 24 weeks
Thats because while both drugs target GLP-1 receptors, tirzepatide also works on the GIP receptor, Dr